2024, Communication, FDA and Packaging - Pharmacy Technician Pulse

DSCSA Compliance for Independent Pharmacies

DiversifyRx

NOVEMBER 24, 2023

While DSCSA (the Drug Supply Chain Security Act) enforcement is postponed until November 2024, it is critical to move forward in becoming compliant sooner rather than later. This tracking involves the use of unique product identifiers, such as serial numbers and barcodes, on drug packaging to track their movement.

Independent Pharmacies

Independent Pharmacies Packaging Documentation FDA

Clinical trials for rare diseases

European Pharmaceutical Review

MARCH 28, 2024

FDA is expected to provide initial feedback on the data submitted by July 2024, with further data to be collected and analysed over the next two years. What is the main reason submission of the DVA qualification to FDA is significant for future clinical trials?

FDA

FDA Packaging Insurance Communication

DSCSA Compliance for Independent Pharmacies

Clinical trials for rare diseases

Stay Connected